Sumatriptan Succinate

Medication for migraine

key word:

migraine Medication

Category:

Consulting

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strives to build a large health  industry finance platform company integrating pharmaceutical, intelligent medical, bio pharm®aceutical R&D, industrial production and sales.

The chemical reactions involved in the existing products include Foucault rea≈ction, nitration reaction, sulfonation reaction, hydrogenation reaction, fluorination reaction, c¶hlorination reaction, bromination reaction, diazotization reaction, format reactio∞n, etc.

Medication for migraine

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP 4) inhibitor developed by Merck. In October 2006, Sitagliptin♥ phosphate Januvia was approved by FDA as the first D<PP4 inhibitor for the treatment of type ⅱ diabetes mellitus. The characteristics of this dr'ug are that it can stimulate insulin secretion while reducing hunger withou<t causing weight gain. Hypoglycemia and edema will not occur, and it is suitable for diabetic p•atients with poor blood glucose control and frequent hypoglyλcemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that i☆s market-oriented and realizes industrial development through R&D innovation and t€echnology transformation.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of the most important products fλor the treatment of arthritis. It is well tolerated and has a lo✘w incidence of side effects

Pranlukast

Pranlukast, developed by Ono, is one of the three major  leukotriene receptor antagonists. In clinical application, it has good t​herapeutic effect on atopic asthma and other types of bronchial asthma, and the market prospect i•s huge. In the major category of asthma drugs, leukotriene receptor antagonist→s have the fastest growing market share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is m™arket-oriented and realizes industrial development through R&D inn©ovation and technology transformation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the se•cond drug approved by FDA for Alzheimer's disease in the United States. Its treatment reaches✘ the target dose and has low toxic and side effects. It has been widely rβecognized by our medical community, and good tolerance is its biggeγst advantage. In October 1999, Donepezil was launched εin China under the trade name "Aricept", which is the main ch≤emical drug against Alzheimer's disease. At present, CFDA‍ has approved a number of domestic enterprises to produce donepezil preparations, the ☆main dosage forms are tablets, capsules, dispersive tablets, oral disintegrating tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (Eliquis, Bristol-Myers Sq♠uibb/Pfizer), a direct oral factor Xa inhibitor, was approved for use in the 27 EU member s™tates. The world's first drug approved to prevent venous t÷hromboembolism (VTE) in adult patients undergoing elective hip or knee replacement. Fro©m June 2019 to June 2020, the annual sales of apixaban pro≤ducts overseas reached about $15.4 billion, with a★ year-on-year growth of nearly 32%, and the API consumption reached about 23,960 kg, with a year-÷on-year growth of about 28%. Compared with its main competitor, Rivaroxaba™n, the drug's annual overseas sales are about $4.5  billion higher.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-oβriented and realizes industrial development through R&D inn ovation and technology transformation.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and manufactured by G>enzyme. On December 29, 2004, it was approved by FDA for the treatment of refractory or relaσpsed acute lymphoblastic leukemia (ALL) in children.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharma'ceutical enterprise that is market-oriented and realizes industrial development thr¥ough R&D innovation and technology transformation.

Product Consulting

Our staff will contact you within 24 hours (working days). If you need other services,& E-mail: 2880705932@qq.com
Submit

Copyright © 2022 Anhui Union Pharmaceuticals Technology Co., Ltd.